• Strata Critical Medical completed the acquisition of Heart and Lung Transplant National Recovery Program, a U.S. provider of transplant surgical recovery services.
• Transaction valued at USD 21.5 million, funded about 80% in cash, 20% in stock tied to a multi-year lockup.
• HLT-NRP expected to generate about USD 10 million revenue, USD 3.1 million Adjusted EBITDA in 2026.
• Deal expands Strata’s transplant surgeon network, boosting coverage in key markets including Florida, California.
• Purchase price set at a mid-single-digit multiple of Adjusted EBITDA, before synergies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Strata Critical Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606240900PRIMZONEFULLFEED9751701) on June 24, 2026, and is solely responsible for the information contained therein.